COMMUNIQUÉS West-GlobeNewswire

Forty Seven Inc. to Report Fourth Quarter and Full Year 2018 Financial Results on Thursday, March 28, 2019
21/03/2019
MENLO PARK, Calif., March 21, 2019 (GLOBE NEWSWIRE) -- Forty Seven Inc. (NASDAQ:FTSV), a clinical-stage, immuno-oncology company focused on developing therapies to activate macrophages in the fight against cancer, today [...]
Oxford Immunotec Announces Chief Financial Officer Transition
21/03/2019
OXFORD, United Kingdom and MARLBOROUGH, Mass., March 21, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today announced that Richard [...]
TearLab Corporation Reports Fourth Quarter and Full Year 2018 Financial Results
21/03/2019
ESCONDIDO, Calif., March 21, 2019 (GLOBE NEWSWIRE) -- TearLab Corporation (OTCQB:TEAR) (“TearLab” or the “Company”) today reported its consolidated financial results for the fourth quarter and twelve months ended [...]
Gritstone Oncology Announces First Patient Dosed in a Clinical Study Evaluating its Personalized Immunotherapy, GRANITE-001
21/03/2019
EMERYVILLE, Calif., March 21, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer [...]
Aducanumab Failure: Selectivity for the Toxic Oligomer is Essential to Treating Root Cause of Alzheimer’s Disease
21/03/2019
Discontinued aducanumab phase 3 studies emphasize urgent need for therapies that target the toxic oligomer with exacting precision TORONTO and CAMBRIDGE, Mass., March 21, 2019 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, [...]
DEINOVE passes the first milestone of the AGIR programm and receives €1.5m from Bpifrance
21/03/2019
DEINOVE passes the first milestone of the AGIR programm and receives €1.5m from Bpifrance The robotic platform for extracting and screening antibiotic activities from bacterial strains is now operational for the [...]
Nymox Teleconference Monday, March 25 10:00 a.m. EDT
21/03/2019
HASBROUCK HEIGHTS, N.J., March 21, 2019 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) Nymox will hold a teleconference for shareholders on Monday, March 25 at 10:00 a.m. Eastern Daylight Time (EDT [...]
Tabula Rasa HealthCare Co-Founder and President to Receive Fellow Award from the American Pharmacists Association
21/03/2019
Orsula V. Knowlton, PharmD, MBA to be Inducted a Fellow at 2019 APhA Annual Meeting MOORESTOWN, N.J., March 21, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc . (TRHC) (NASDAQ: TRHC) President Orsula V. Knowlton, [...]
The Science Behind Medical Marijuana is Flawed -- CFN Media
21/03/2019
SEATTLE, March 21, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces the publication [...]
Stryker to host conference call on April 23, 2019
21/03/2019
Kalamazoo, Michigan, March 21, 2019 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Tuesday, April 23, 2019 at 4:30 p.m., Eastern Time, to discuss the Company's operating results [...]
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
21/03/2019
ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ): In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation), ALK-Abelló A/S shall report the following [...]
Imperial County Brings New Short-Term Crisis Residential Treatment Facility to Meet Growing Community Needs for Behavioral Health Services with Innovative Public + Private Strategic Partnership
21/03/2019
EL CENTRO, Calif., March 21, 2019 (GLOBE NEWSWIRE) -- Imperial County Behavioral Health Services is partnering with Alvarado Parkway Institute Behavioral Health System to bring Jackson House, a short–term acute [...]
Grant of share options and performance shares to members of the Board of Management and key employees
21/03/2019
ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ): Share option programme According to the guidelines for incentive payments adopted at the Company's annual general meeting on 13 March 2019, the Board of Directors has passed [...]
Diamond CBD Books Over $300,000 in New Orders in Three Days at ASD Market Week
21/03/2019
Company's CBD-infused edibles, oils, and vapes shine during influential Las Vegas consumer merchandise trade show FT. LAUDERDALE, Fla., March 21, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Diamond CBD Inc., a wholly- [...]
Resolutions from the Annual General Meeting of Novo Nordisk A/S
21/03/2019
Bagsværd, Denmark, 21 March 2019 - Today, Novo Nordisk A/S held its Annual General Meeting, at which the following resolutions were adopted: Financial year 2018 and 2019 The Company's statutory Annual Report 2018. The [...]
Zealand Pharma announces completion of the share subscription by Alexion Pharmaceuticals, Inc. and registration of capital increase
21/03/2019
Company announcement – No. 8/2019 Zealand Pharma announces completion of the share subscription by Alexion Pharmaceuticals, Inc. and registration of capital increase Zealand Pharma A/S has today registered a capital [...]
Farmako: World's Largest Import Contract for Pharmaceutical Cannabis
21/03/2019
German Farmako secures 50 tonnes of flowers and oils from Polish company Pharmacann Polska FRANKFURT, March 21, 2019 (GLOBE NEWSWIRE) -- Farmako will import 50 tonnes of pharmaceutical cannabis from Pharmacann Polska [...]
Scapa Healthcare Introduces a Second-Generation Hydrocolloid Adhesive
21/03/2019
Hydrocolloid Gen II Provides Repositionability and High Absorption Properties WINDSOR, Conn., March 21, 2019 (GLOBE NEWSWIRE) -- Scapa Healthcare , a leading strategic outsource partner of skin friendly turn-key [...]
Momenta Pharmaceuticals Announces Publication of New Data Supporting M281 as First Anti-FcRn Antibody to Inhibit Maternal-Fetal IgG Transfer in the Human Term Placenta
21/03/2019
Data supports M281’s potential to prevent placental transfer of disease-inducing antibodies from mother to fetus in alloimmune and autoimmune diseases of the fetus and newborn Global multi-center Phase 2 study of M281 [...]

Pages